Literature DB >> 21055468

MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.

Michaela Durigova1, Hideaki Nagase, John S Mort, Peter J Roughley.   

Abstract

Aggrecan degradation in articular cartilage occurs predominantly through proteolysis and has been attributed to the action of members of the matrix metalloproteinase (MMP) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) families. Both families of enzymes cleave aggrecan at specific sites within the aggrecan core protein. One cleavage site within the interglobular domain (IGD), between Glu(373-374)Ala and five additional sites in the chondroitin sulfate-2 (CS-2) region of aggrecan were characterized as "aggrecanase" (ADAMTS) cleavage sites, while cleavage between Ser(341-342)Phe within the IGD of bovine aggrecan is attributed to MMP action. The objective of this study was to assess the cleavage efficiency of MMPs relative to ADAMTS and their contribution to aggrecan proteolysis in vitro. The analysis of aggrecan IGD degradation in bovine articular cartilage explants treated with catabolic cytokines over a 19-day period showed that MMP-mediated degradation of aggrecan within the IGD can only be observed following day 12 of culture. This delay is associated with the lack of activation of proMMPs during the first 12 days of culture. Analysis of MMP1, 2, 3, 7, 8, 9, 12, 13 and ADAMTS5 efficiencies at cleaving within the aggrecan IGD and CS-2 region in vitro was carried out by the digestion of bovine aggrecan with the various enzymes and Western blot analysis using aggrecan anti-G1 and anti-G3 antibodies. Of these MMPs, MMP12 was the most efficient at cleaving within the aggrecan IGD. In addition to cleavage in the IGD, MMP, 3, 7, 8 and 12 were also able to degrade the aggrecan CS-2 region. MMP3 and MMP12 were able to degrade aggrecan at the very C-terminus of the CS-2 region, cleaving the Glu(2047-2048)Ala bond which was previously shown to be cleaved by ADAMTS5. However, in comparison to ADAMTS5, MMP3 was about 100 times and 10 times less efficient at cleaving within the aggrecan IGD and CS-2 regions, respectively. Collectively, our results showed that the delayed activation of proMMPs and the relatively low cleavage efficiency of MMPs can explain the minor contribution of these enzymes to aggrecan catabolism in vivo. This study also uncovered a potential role for MMPs in the C-terminal truncation of aggrecan.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21055468      PMCID: PMC3057330          DOI: 10.1016/j.matbio.2010.10.007

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  64 in total

Review 1.  The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage.

Authors:  T E Hardingham; A J Fosang; J Dudhia
Journal:  Eur J Clin Chem Clin Biochem       Date:  1994-04

2.  Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.

Authors:  A J Fosang; K Last; V Knäuper; P J Neame; G Murphy; T E Hardingham; H Tschesche; J A Hamilton
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

3.  Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.

Authors:  A J Fosang; K Last; P J Neame; G Murphy; V Knäuper; H Tschesche; C E Hughes; B Caterson; T E Hardingham
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

4.  The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.

Authors:  A J Fosang; P J Neame; K Last; T E Hardingham; G Murphy; J A Hamilton
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

5.  Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation.

Authors:  D J Buttle; C J Handley; M Z Ilic; J Saklatvala; M Murata; A J Barrett
Journal:  Arthritis Rheum       Date:  1993-12

6.  Signal transduction through chondrocyte integrin receptors induces matrix metalloproteinase synthesis and synergizes with interleukin-1.

Authors:  E C Arner; M D Tortorella
Journal:  Arthritis Rheum       Date:  1995-09

7.  Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain.

Authors:  M W Lark; J T Gordy; J R Weidner; J Ayala; J H Kimura; H R Williams; R A Mumford; C R Flannery; S S Carlson; M Iwata
Journal:  J Biol Chem       Date:  1995-02-10       Impact factor: 5.157

8.  Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.

Authors:  A J Fosang; P J Neame; T E Hardingham; G Murphy; J A Hamilton
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage.

Authors:  C R Flannery; M W Lark; J D Sandy
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

10.  Changes in cartilage composition and physical properties due to stromelysin degradation.

Authors:  L J Bonassar; E H Frank; J C Murray; C G Paguio; V L Moore; M W Lark; J D Sandy; J J Wu; D R Eyre; A J Grodzinsky
Journal:  Arthritis Rheum       Date:  1995-02
View more
  28 in total

1.  Lentiviral vector-mediated over-expression of Sox9 protected chondrocytes from IL-1β induced degeneration and apoptosis.

Authors:  Huading Lu; Chun Zeng; Mingwei Chen; Liyi Lian; Yuhu Dai; Huiqing Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc disease.

Authors:  Xin Wang; Hua Wang; Hao Yang; Jun Li; Qiqing Cai; Irving M Shapiro; Makarand V Risbud
Journal:  Am J Pathol       Date:  2014-07-22       Impact factor: 4.307

3.  Detrimental effects of discectomy on intervertebral disc biology can be decelerated by growth factor treatment during surgery: a large animal organ culture model.

Authors:  Svenja Illien-Jünger; Young Lu; Devina Purmessur; Jillian E Mayer; Benjamin A Walter; Peter J Roughley; Sheeraz A Qureshi; Andrew C Hecht; James C Iatridis
Journal:  Spine J       Date:  2014-04-24       Impact factor: 4.166

4.  Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.

Authors:  M Durigova; L Troeberg; H Nagase; P J Roughley; J S Mort
Journal:  Eur Cell Mater       Date:  2011-01-12       Impact factor: 3.942

Review 5.  Matrix Metalloproteinases During Axonal Regeneration, a Multifactorial Role from Start to Finish.

Authors:  Lien Andries; Inge Van Hove; Lieve Moons; Lies De Groef
Journal:  Mol Neurobiol       Date:  2016-02-29       Impact factor: 5.590

6.  An enzyme-sensitive PEG hydrogel based on aggrecan catabolism for cartilage tissue engineering.

Authors:  Stacey C Skaalure; Stanley Chu; Stephanie J Bryant
Journal:  Adv Healthc Mater       Date:  2014-10-08       Impact factor: 9.933

7.  Chondroadherin fragmentation mediated by the protease HTRA1 distinguishes human intervertebral disc degeneration from normal aging.

Authors:  Bashar Akhatib; Patrik Onnerfjord; Rahul Gawri; Jean Ouellet; Peter Jarzem; Dick Heinegård; John Mort; Peter Roughley; Lisbet Haglund
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

8.  Aggrecanases in the human synovial fluid at different stages of osteoarthritis.

Authors:  Enshui Zhang; Xinfeng Yan; Ming Zhang; Xiaotian Chang; Zhengwu Bai; Yeteng He; Zhen Yuan
Journal:  Clin Rheumatol       Date:  2013-01-31       Impact factor: 2.980

9.  Genotoxic stress accelerates age-associated degenerative changes in intervertebral discs.

Authors:  Luigi A Nasto; Dong Wang; Andria R Robinson; Cheryl L Clauson; Kevin Ngo; Qing Dong; Peter Roughley; Michael Epperly; Saiful M Huq; Enrico Pola; Gwendolyn Sowa; Paul D Robbins; James Kang; Laura J Niedernhofer; Nam V Vo
Journal:  Mech Ageing Dev       Date:  2012-12-19       Impact factor: 5.432

10.  Kaposi's sarcoma: a computational approach through protein-protein interaction and gene regulatory networks analysis.

Authors:  Aubhishek Zaman; Md Habibur Rahaman; Samsad Razzaque
Journal:  Virus Genes       Date:  2012-12-25       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.